0001505497
EX-FILING FEES
0001505497
2025-11-18
2025-11-18
0001505497
1
2025-11-18
2025-11-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Table
FORM
S-8
(Form
Type)
BIORESTORATIVE
THERAPIES, INC.
(Exact
Name of Registrant as Specified in its Charter)
Table
1: Newly Registered Securities
Fees
| | |
| |
| | |
| | |
| | |
| |
| | |
| |
| Security
Type | |
Security
Class Title | |
Fee
Calculation Rule | | |
Amount
Registered | | |
Proposed
Maximum Offering Price Per Unit | | |
Maximum
Aggregate Offering Price | |
Fee
Rate | | |
Amount
of Registration Fee | |
| Equity | |
Common
Stock, par value $0.0001 per share | |
457(h)(1) | | |
3,000,000(1) | | |
$1.30(2) | | |
$3,900,000 | |
0.00013810 | | |
$538.59 | |
| Total
Offering Amounts | |
| | |
$3,900,000 | |
| | |
$538.59 | |
| Total
Fee Offsets | |
| | |
| |
| | |
— | |
| Net
Fee Due | |
| | |
| |
| | |
$538.59 | |
| |
(1) |
Pursuant to Rule 416(a) under
the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional
shares of the Registrant’s common stock that become issuable as a result of any stock dividend, stock split, recapitalization,
or other similar transaction effected without the receipt of consideration that results in an increase in the number of outstanding
shares of the Registrant’s common stock. |
| |
(2) |
Calculated solely for purposes
of the registration fee for this offering and in accordance with paragraph (h)(1) of Rule 457 of the Securities Act, on the basis of
the average of the high and low prices of the Registrant’s shares of common stock as quoted on the Nasdaq Capital Market on November
14, 2025. |
N/A